LY517717
-
LY517717
structure -
-
CAS No:
313489-71-3
-
Formula:
C27H33N5O2
-
Chemical Name:
LY517717
-
Synonyms:
LY-517717 (LY 517717;LY 517717;N-[(1R)-2-[4-(1-Methyl-4-piperidinyl)-1-piperazinyl]-2-oxo-1-phenylethyl]-1H-indole-6-carboxaMide;1H-Indole-6-carboxamide, N-[(1R)-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxo-1-phenylethyl]-
-
CAS No:
Description
LY517717 is an investigational oral direct inhibitor of activated Factor Xa. It is believed to be Lilly's PMD-3112 (licensed from Amgen).
Drug Information
Investigated for use/treatment in thrombosis and venous thromboembolism.
LY517717 has been well tolerated in healthy subjects. LY517717 is a blood thinner that may prevent blood clots from forming in the legs and may prevent those blood clots from traveling to the lungs. Leg and lung blood clots occur commonly after patients have surgery to replace a hip or knee joint. These clots often occur while patients are in bed in the hospital after hip or knee joint surgery.
LY517717, an investigational oral direct inhibitor of activated Factor Xa, appears to interrupt thrombus formation without impairing platelet hemostatic function.
LY 517717
LY517717 Use and Manufacturing
As an orally active factor Xa inhibitor; an anticoagulant, LY 517717 is a candidate for use in venous thromboembolism prevention in major orthopedic surgery.
Computed Properties
Molecular Weight:459.6
XLogP3:3
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:5
Exact Mass:459.26342531
Monoisotopic Mass:459.26342531
Topological Polar Surface Area:71.7
Heavy Atom Count:34
Complexity:695
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation